Oxytocin Infusion Protocol Guidelines

Critical Safety Monitoring

The American Academy of Pediatrics recommends having a defibrillator immediately available when administering oxytocin 1
The guideline society recommends stopping infusion immediately if baseline intrauterine pressure reaches 40 mmHg 2
The guideline society recommends discontinuing oxytocin for Category II or III fetal heart rate patterns 2
The guideline society recommends repositioning the patient to left lateral decubitus position when stopping oxytocin 2
The guideline society recommends administering supplemental oxygen at 6-10 L/min when stopping oxytocin 2
The guideline society recommends initiating IV fluid bolus when stopping oxytocin 2
The guideline society recommends performing immediate vaginal examination to assess for rapid descent, cord prolapse, or rupture signs when stopping oxytocin 2
The guideline society recommends considering terbutaline tocolysis if fetal heart rate abnormalities develop when stopping oxytocin 2

The American College of Obstetricians and Gynecologists recommends never using oxytocin in cephalopelvic disproportion, as 25-40% of arrest disorders have associated CPD 3
The guideline society recommends avoiding oxytocin in first-trimester pregnancy losses (blighted ovum, anembryonic pregnancy) as oxytocin requires intact pregnancy and labor mechanism 4
The World Health Organization recommends not giving oxytocin beyond 3 hours after birth for postpartum hemorrhage, as benefit disappears and potential harm increases 5

The American Academy of Pediatrics recommends not using "rule of 6" calculations, as standardized concentrations reduce medication errors 1
The guideline society recommends avoiding rapid bolus administration during labor (reserved for postpartum use only) is not cited, however, not increasing doses more frequently than every 40 minutes is implied to increase hyperstimulation risk without improving efficacy, though not directly cited here, it is cited in the context of CPD 3